Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$34.63 USD
-1.37 (-3.81%)
Updated Nov 4, 2025 04:00 PM ET
After-Market: $34.61 -0.02 (-0.06%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Viking Therapeutics, Inc. has a market cap of $420.90M, which represents its share price of $5.38 multiplied by its outstanding shares number of 78.24M. As a small-cap company, VKTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
VKTX 34.63 -1.37(-3.81%)
Will VKTX be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for VKTX
Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing
Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
Other News for VKTX
Is VKTX preparing to trend higher? Upper Bollinger Band Walk shows up after crashing 5.46%
Sell Novo Nordisk And Buy Viking Therapeutics
Best And Worst Stocks And ETFs Through October
Is VKTX likely to continue higher? Golden Cross shows up after sinking 0.24%
Wayfair, Energy Transfer, Viking, IREN, Bloom: Trending by Analysts